"Molecule ChEMBL ID;""Molecule Name"";""Molecule Max Phase"";""Molecular Weight"";""#RO5 Violations"";""AlogP"";""Compound Key"";""Smiles"";""Standard Type"";""Standard Relation"";""Standard Value"";""Standard Units"";""pChEMBL Value"";""Data Validity Comment"";""Comment"";""Uo Units"";""Ligand Efficiency BEI"";""Ligand Efficiency LE"";""Ligand Efficiency LLE"";""Ligand Efficiency SEI"";""Potential Duplicate"";""Assay ChEMBL ID"";""Assay Description"";""Assay Type"";""BAO Format ID"";""BAO Label"";""Assay Organism"";""Assay Tissue ChEMBL ID"";""Assay Tissue Name"";""Assay Cell Type"";""Assay Subcellular Fraction"";""Assay Parameters"";""Assay Variant Accession"";""Assay Variant Mutation"";""Target ChEMBL ID"";""Target Name"";""Target Organism"";""Target Type"";""Document ChEMBL ID"";""Source ID"";""Source Description"";""Document Journal"";""Document Year"";""Cell ChEMBL ID"";""Properties"";""Action Type"";""Standard Text Value"";""Value""",,,,,,,,
"CHEMBL5780498;"""";""None"";""613.67"";""1"";""1.01"";""BDBM500061"";""O=C1CCC(N2Cc3c(NC(=O)[C@@H]4C[C@H](O)CN4CCNC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041959"";""UO_0000065"";""10.69"";""0.20"";""5.55"";""3.97"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5845659;"""";""None"";""471.51"";""0"";""2.85"";""BDBM500066"";""CC(Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O)=C1C(=O)CC(c2ccccc2)CC1=O"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041964"";""UO_0000065"";""12.99"";""0.24"";""3.27"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL6037868;"""";""None"";""487.51"";""0"";""1.82"";""BDBM500067"";""O=C1CCC(N2Cc3c(NC(CO)=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041965"";""UO_0000065"";""13.46"";""0.25"";""4.74"";""4.94"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL6024368;"""";""None"";""533.58"";""1"";""3.99"";""BDBM500068"";""O=C1CCC(N2Cc3c(NC(=C4C(=O)CC(c5ccccc5)CC4=O)c4ccccc4)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1041966"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL5793703;"""";""None"";""575.62"";""1"";""2.50"";""BDBM500098"";""COCCOCCOc1ccccc1C1CC(=O)C(=CNc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)C(=O)C1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041996"";""UO_0000065"";""11.40"";""0.21"";""4.06"";""4.67"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL1905947;"""";""None"";""342.44"";""0"";""1.90"";""BDBM585031"";""O=C1CC(c2ccccc2)CC(=O)C1=CNCCCN1CCOCC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230267"";""UO_0000065"";""14.73"";""0.28"";""3.15"";""8.60"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL6004748;"""";""None"";""609.86"";""1"";""4.36"";""BDBM500005"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5c(Br)ccc6[nH]cc(Cl)c56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041908"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL6033868;"""";""None"";""513.58"";""1"";""3.67"";""BDBM500033"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5csc6ccccc56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041931"";""UO_0000065"";""11.93"";""0.23"";""2.45"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5773188;"""";""None"";""556.62"";""1"";""2.75"";""BDBM500042"";""O=C1CCC(N2Cc3c(NC(=O)CCCCNC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1041940"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL5760142;"""";""None"";""626.71"";""1"";""1.19"";""BDBM500050"";""O=C1CCC(N2Cc3c(NC(=O)CN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041948"";""UO_0000065"";""9.77"";""0.18"";""4.93"";""4.13"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5804170;"""";""None"";""883.02"";""3"";""0.27"";""BDBM500056"";""CC(C)[C@H](NC(=O)CN1CCN(CCNC=C2C(=O)CC(c3ccccc3)CC2=O)CC1)C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041954"";""UO_0000065"";""7.43"";""0.14"";""6.29"";""2.51"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5924020;"""";""None"";""611.70"";""1"";""2.29"";""BDBM500057"";""O=C1CCC(N2Cc3c(NC(=O)C4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041955"";""UO_0000065"";""10.01"";""0.19"";""3.83"";""4.22"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5889540;"""";""None"";""759.86"";""2"";""1.32"";""BDBM500113"";""O=C1CCC(N2C(=O)c3cccc(OCCOCCOCCOCCN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)c3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042011"";""UO_0000065"";""8.63"";""0.16"";""5.24"";""3.79"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5789574;"""";""None"";""575.42"";""1"";""3.70"";""BDBM500137"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5cc6[nH]ccc6cc5Br)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042035"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5971505;"""";""None"";""530.97"";""1"";""3.59"";""BDBM500138"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5c[nH]c6cccc(Cl)c56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042036"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5941263;"""";""None"";""670.72"";""2"";""1.44"";""BDBM500073"";""O=C1CCC(N2C(=O)c3cccc(NC(=O)OCCN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)c3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041971"";""UO_0000065"";""9.78"";""0.18"";""5.12"";""3.76"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5812495;"""";""None"";""531.59"";""1"";""2.72"";""BDBM500111"";""O=C1CCC(N2Cc3c(NC(=O)CSC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1042009"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL5994573;"""";""None"";""475.48"";""0"";""2.60"";""BDBM500020"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ccccc5F)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041918"";""UO_0000065"";""12.88"";""0.24"";""3.52"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5929873;"""";""None"";""513.58"";""1"";""3.67"";""BDBM500023"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5cccc6sccc56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041921"";""UO_0000065"";""11.93"";""0.23"";""2.45"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5764921;"""";""None"";""557.61"";""1"";""4.77"";""BDBM500026"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5c6ccccc6cc6ccccc56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041924"";""UO_0000065"";""10.98"";""0.20"";""1.35"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5988005;"""";""None"";""547.61"";""1"";""4.05"";""BDBM500031"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ccccc5Cc5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041929"";""UO_0000065"";""11.18"";""0.20"";""2.07"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL4856314;"""";""None"";""507.59"";""2"";""6.25"";""14f"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(-c4ccnn4Cc4ccccc4)cc3oc2=O)c1"";""IC50"";"""";"""";"""";"""";"""";""Not Active"";"""";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";"""";"""";""""",,,,,,,,
"CHEMBL4853955;"""";""None"";""431.49"";""0"";""4.74"";""14h"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(-c4ccnn4C)cc3oc2=O)c1"";""IC50"";""'='"";""346300.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""346.3""",,,,,,,,
"CHEMBL5557214;"""";""None"";""287.36"";""0"";""1.13"";""LC3in-C38"";""CN(C)CCNC=C1C(=O)CC(c2ccccn2)CC1=O"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL4851652;"""";""None"";""480.52"";""0"";""4.53"";""14q"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(NC(=O)CCCC(=O)O)cc3oc2=O)c1"";""IC50"";""'='"";""386000.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""386.0""",,,,,,,,
"CHEMBL5562185;"""";""None"";""342.44"";""0"";""1.82"";""LC3in-C1"";""Cc1ccc(C2CC(=O)C(=CNCCN3CCOCC3)C(=O)C2)cc1"";""IC50"";""'='"";""1810.0"";""nM"";""5.74"";"""";"""";""UO_0000065"";""16.77"";""0.31"";""3.92"";""9.79"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""1.81""",,,,,,,,
"CHEMBL5532542;"""";""None"";""355.27"";""0"";""3.04"";""LC3in-C35"";""CN(C)CCNC=C1C(=O)CC(c2ccc(Cl)cc2Cl)CC1=O"";""IC50"";""'='"";""310.0"";""nM"";""6.51"";"""";"""";""UO_0000065"";""18.32"";""0.39"";""3.47"";""13.17"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.31""",,,,,,,,
"CHEMBL4855220;"""";""None"";""466.49"";""0"";""4.14"";""14p"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(NC(=O)CCC(=O)O)cc3oc2=O)c1"";""IC50"";""'='"";""382300.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""382.3""",,,,,,,,
"CHEMBL4851364;"""";""None"";""614.65"";""2"";""3.71"";""2"";""CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CCC(C)C)c4)c(=O)oc3c2C)OC1(C)C"";""IC50"";""'='"";""72300.0"";""nM"";""4.14"";"""";"""";""UO_0000065"";""6.74"";""0.13"";""0.43"";""2.07"";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""72.3""",,,,,,,,
"CHEMBL4873913;"""";""None"";""397.43"";""0"";""4.06"";""3"";""Cc1c(O)ccc2c(O)c(NC(=O)c3ccc(O)c(CCC(C)C)c3)c(=O)oc12"";""IC50"";""'='"";""250800.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""250.8""",,,,,,,,
"CHEMBL4845679;"""";""None"";""383.40"";""0"";""3.75"";""5"";""CC(C)CCc1cc(C(=O)Nc2c(O)c3ccc(O)cc3oc2=O)ccc1O"";""IC50"";""'='"";""227600.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""227.6""",,,,,,,,
"CHEMBL4851863;"""";""None"";""392.41"";""0"";""2.69"";""13c"";""CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)Nc1c(O)c2ccc(O)cc2oc1=O"";""IC50"";"""";"""";"""";"""";"""";""Not Active"";"""";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";"""";"""";""""",,,,,,,,
"CHEMBL4871486;"""";""None"";""381.43"";""0"";""4.35"";""4"";""Cc1c(O)ccc2c(O)c(NC(=O)c3cccc(CCC(C)C)c3)c(=O)oc12"";""IC50"";""'='"";""260900.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""260.9""",,,,,,,,
"CHEMBL4858429;"""";""None"";""364.35"";""0"";""2.06"";""13b"";""C[C@H](NC(=O)OC(C)(C)C)C(=O)Nc1c(O)c2ccc(O)cc2oc1=O"";""IC50"";""'='"";""921900.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""921.9""",,,,,,,,
"CHEMBL4852185;"""";""None"";""406.44"";""0"";""3.08"";""13f"";""CC[C@H](C)[C@H](NC(=O)OC(C)(C)C)C(=O)Nc1c(O)c2ccc(O)cc2oc1=O"";""IC50"";"""";"""";"""";"""";"""";""Not Active"";"""";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";"""";"""";""""",,,,,,,,
"CHEMBL4872970;"""";""None"";""445.52"";""1"";""5.22"";""14g"";""CCn1nccc1-c1ccc2c(O)c(NC(=O)c3cccc(CCC(C)C)c3)c(=O)oc2c1"";""IC50"";""'='"";""320000.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""320.0""",,,,,,,,
"CHEMBL5558626;"""";""None"";""257.33"";""0"";""2.50"";""LC3in-C7"";""CCNC=C1C(=O)CC(c2ccc(C)cc2)CC1=O"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL5559211;"""";""None"";""300.40"";""0"";""2.05"";""LC3in-C10"";""Cc1ccc(C2CC(=O)C(=CNCCN(C)C)C(=O)C2)cc1"";""IC50"";""'='"";""1210.0"";""nM"";""5.92"";"""";"""";""UO_0000065"";""19.70"";""0.37"";""3.87"";""11.98"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""1.21""",,,,,,,,
"CHEMBL5558722;"""";""None"";""303.43"";""0"";""2.85"";""LC3in-C14"";""CSCCNC=C1C(=O)CC(c2ccc(C)cc2)CC1=O"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL5542544;"""";""None"";""328.46"";""0"";""2.83"";""LC3in-C16"";""Cc1ccc(C2CC(=O)C(=CNCCCCN(C)C)C(=O)C2)cc1"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL5566225;"""";""None"";""300.40"";""0"";""2.05"";""LC3in-C18"";""Cc1ccccc1C1CC(=O)C(=CNCCN(C)C)C(=O)C1"";""IC50"";""'='"";""920.0"";""nM"";""6.04"";"""";"""";""UO_0000065"";""20.09"";""0.37"";""3.99"";""12.22"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.92""",,,,,,,,
"CHEMBL5560736;"""";""None"";""320.82"";""0"";""2.39"";""LC3in-C27"";""CN(C)CCNC=C1C(=O)CC(c2cccc(Cl)c2)CC1=O"";""IC50"";""'='"";""370.0"";""nM"";""6.43"";"""";"""";""UO_0000065"";""20.05"";""0.40"";""4.04"";""13.02"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.37""",,,,,,,,
"CHEMBL5561502;"""";""None"";""355.27"";""0"";""3.04"";""LC3in-C34"";""CN(C)CCNC=C1C(=O)CC(c2c(Cl)cccc2Cl)CC1=O"";""IC50"";""'='"";""200.0"";""nM"";""6.70"";"""";"""";""UO_0000065"";""18.86"";""0.40"";""3.66"";""13.56"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.2""",,,,,,,,
"CHEMBL4851932;"""";""None"";""367.40"";""0"";""4.05"";""6a"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(O)cc3oc2=O)c1"";""IC50"";""'='"";""139600.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""139.6""",,,,,,,,
"CHEMBL4869659;"""";""None"";""397.43"";""0"";""4.05"";""11"";""COc1ccc(C(=O)Nc2c(O)c3ccc(O)cc3oc2=O)cc1CCC(C)C"";""IC50"";""'='"";""143000.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""143.0""",,,,,,,,
"CHEMBL4873468;"""";""None"";""406.44"";""0"";""3.23"";""13g"";""CCCC[C@H](NC(=O)OC(C)(C)C)C(=O)Nc1c(O)c2ccc(O)cc2oc1=O"";""IC50"";""'='"";""667700.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""667.7""",,,,,,,,
"CHEMBL5562048;"""";""None"";""319.40"";""0"";""3.68"";""LC3in-C9"";""Cc1ccc(C2CC(=O)C(=CNCc3ccccc3)C(=O)C2)cc1"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL5561184;"""";""None"";""316.40"";""0"";""1.75"";""LC3in-C21"";""COc1cccc(C2CC(=O)C(=CNCCN(C)C)C(=O)C2)c1"";""IC50"";""'='"";""1270.0"";""nM"";""5.90"";"""";"""";""UO_0000065"";""18.64"";""0.35"";""4.15"";""10.05"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""1.27""",,,,,,,,
"CHEMBL5562227;"""";""None"";""304.36"";""0"";""1.88"";""LC3in-C24"";""CN(C)CCNC=C1C(=O)CC(c2cccc(F)c2)CC1=O"";""IC50"";""'='"";""610.0"";""nM"";""6.21"";"""";"""";""UO_0000065"";""20.42"";""0.39"";""4.33"";""12.58"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.61""",,,,,,,,
"CHEMBL5568495;"""";""None"";""365.27"";""0"";""2.50"";""LC3in-C31"";""CN(C)CCNC=C1C(=O)CC(c2ccc(Br)cc2)CC1=O"";""IC50"";""'='"";""950.0"";""nM"";""6.02"";"""";"""";""UO_0000065"";""16.49"";""0.37"";""3.52"";""12.19"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.95""",,,,,,,,
"CHEMBL4878719;"""";""None"";""477.56"";""1"";""7.16"";""14a"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(-c4cccc5ccccc45)cc3oc2=O)c1"";""IC50"";""'='"";""225300.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""225.3""",,,,,,,,
"CHEMBL4873678;"""";""None"";""471.51"";""1"";""5.70"";""14c"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(-c4ccc(C(=O)O)cc4)cc3oc2=O)c1"";""IC50"";""'='"";""149300.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""149.3""",,,,,,,,
"CHEMBL4856665;"""";""None"";""520.61"";""2"";""5.45"";""14m"";""Cc1ccc(S(=O)(=O)Nc2ccc3c(O)c(NC(=O)c4cccc(CCC(C)C)c4)c(=O)oc3c2)cc1"";""IC50"";""'='"";""89000.0"";""nM"";""4.05"";"""";"""";""UO_0000065"";""7.78"";""0.15"";""-1.40"";""3.22"";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""89.0""",,,,,,,,
"CHEMBL5986305;"""";""None"";""613.65"";""1"";""3.66"";""BDBM500077"";""O=C1CCC(N2Cc3c(NC(=O)OCc4cnc(NC=C5C(=O)CC(c6ccccc6)CC5=O)s4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041975"";""UO_0000065"";""9.98"";""0.19"";""2.46"";""3.74"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5829143;"""";""None"";""716.80"";""1"";""2.65"";""BDBM500087"";""O=C1CCC(N2C(=O)c3cccc(NC(=O)c4ccc(CN5CCN(CCNC=C6C(=O)CC(c7ccccc7)CC6=O)CC5)cc4)c3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041985"";""UO_0000065"";""9.15"";""0.17"";""3.91"";""3.97"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5787475;"""";""None"";""713.79"";""2"";""1.53"";""BDBM500055"";""CC(C)[C@H](NC=C1C(=O)CC(c2ccccc2)CC1=O)C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1041953"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL6049203;"""";""None"";""485.50"";""0"";""2.49"";""BDBM500069"";""CC(Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O)=C1C(=O)CC(c2ccccc2)CC1=O"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1041967"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL5748015;"""";""None"";""564.52"";""1"";""3.96"";""BDBM500010"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5cccc6[nH]cc(C(F)(F)F)c56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041909"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5993350;"""";""None"";""550.41"";""1"";""3.53"";""BDBM500016"";""Cc1ccc(C2CC(=O)C(=CNc3cccc4c3CN(C3CCC(=O)NC3=O)C4=O)C(=O)C2)c(Br)c1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041914"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5756139;"""";""None"";""544.95"";""1"";""3.23"";""BDBM500003"";""O=C1CCC(N2C(=O)c3cccc(NC=C4C(=O)CC(c5cccc6[nH]cc(Cl)c56)CC4=O)c3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041906"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL6039270;"""";""None"";""577.60"";""1"";""3.11"";""BDBM500054"";""O=C1CCC(N2Cc3c(NC(=O)c4cncc(NC=C5C(=O)CC(c6ccccc6)CC5=O)c4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041952"";""UO_0000065"";""11.36"";""0.21"";""3.45"";""4.24"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5922669;"""";""None"";""700.79"";""2"";""1.82"";""BDBM500080"";""O=C1CCC(N2Cc3c(NC(=O)OCCOCCN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041978"";""UO_0000065"";""9.36"";""0.18"";""4.74"";""3.94"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5935328;"""";""None"";""458.47"";""0"";""1.57"";""BDBM500114"";""O=C1CCC(N2Cc3c(N/C=C4\C(=O)CC(c5ccccc5)NC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1042012"";""UO_0000065"";""13.36"";""0.25"";""4.55"";""4.91"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5879998;"""";""None"";""463.53"";""0"";""2.87"";""BDBM500119"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(C5CCCCC5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042017"";""UO_0000065"";""14.15"";""0.26"";""3.69"";""5.82"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5880655;"""";""None"";""381.39"";""0"";""1.07"";""BDBM500120"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CCCC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1042018"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL6001847;"""";""None"";""596.43"";""1"";""3.24"";""BDBM500131"";""COc1cc(Br)c(C2CC(=O)C(=CNc3cccc4c3CN(C3CCC(=O)NC3=O)C4=O)C(=O)C2)cc1OC"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042029"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5888138;"""";""None"";""552.38"";""1"";""2.93"";""BDBM500136"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5cc(O)ccc5Br)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042034"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5889551;"""";""None"";""530.97"";""1"";""3.59"";""BDBM500140"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5c(Cl)ccc6[nH]ccc56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042038"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL6024116;"""";""None"";""542.59"";""1"";""2.30"";""BDBM500143"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ccccc5N5CCOCC5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042041"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5832063;"""";""None"";""471.47"";""0"";""2.10"";""BDBM500000"";""O=C1CCC(N2C(=O)c3ccc(NC=C4C(=O)CC(c5ccccc5)CC4=O)cc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041903"";""UO_0000065"";""12.99"";""0.24"";""4.02"";""4.72"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5799663;"""";""None"";""280.37"";""0"";""0.75"";""BDBM585001"";""CC1(C)CC(=O)C(=CNCCN2CCOCC2)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230237"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL6051452;"""";""None"";""412.53"";""0"";""1.67"";""BDBM585013"";""CC1(C)CC(=O)C(=CNCCN2CCN(CC(=O)Nc3ccccc3)CC2)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230249"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL3193498;"""";""None"";""403.91"";""0"";""1.99"";""BDBM585015"";""CC(=O)N1CCN(CCNC=C2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230251"";""UO_0000065"";""12.49"";""0.25"";""3.06"";""7.24"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL5560804;"""";""None"";""355.26"";""0"";""3.04"";""LC3in-C32"";""CN(C)CCNC=C1C(=O)CC(c2cccc(Cl)c2Cl)CC1=O"";""IC50"";""'='"";""100.0"";""nM"";""7.00"";"""";"""";""UO_0000065"";""19.70"";""0.42"";""3.96"";""14.17"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.1""",,,,,,,,
"CHEMBL5566715;"""";""None"";""252.36"";""0"";""1.23"";""LC3in-D2"";""CC(C)C1CC(=O)C(=CNCCN(C)C)C(=O)C1"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL2361808;"""";""None"";""474.61"";""0"";""2.74"";""BDBM585009"";""Cc1ccc(NC(=O)CN2CCN(CCNC=C3C(=O)CC(c4ccccc4)CC3=O)CC2)cc1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230245"";""UO_0000065"";""10.63"";""0.20"";""2.31"";""6.17"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL3196992;"""";""None"";""488.63"";""0"";""3.05"";""BDBM585010"";""Cc1ccc(NC(=O)CN2CCN(CCNC=C3C(=O)CC(c4ccc(C)cc4)CC3=O)CC2)cc1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230246"";""UO_0000065"";""10.33"";""0.19"";""2.00"";""6.17"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL1546849;"""";""None"";""461.03"";""0"";""2.51"";""BDBM585014"";""C=CCNC(=S)N1CCN(CCNC=C2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230250"";""UO_0000065"";""10.94"";""0.22"";""2.54"";""7.80"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL5974522;"""";""None"";""383.49"";""0"";""1.88"";""BDBM585022"";""CC1(C)CC(=O)C(=CNCCN2CCN(C(=O)c3ccccc3)CC2)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230258"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5820271;"""";""None"";""498.42"";""0"";""2.60"";""BDBM500125"";""O=C1CCC(N2Cc3c(N/C=C4\C(=O)Nc5cc(C(F)(F)F)ccc5C4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1042023"";""UO_0000065"";""12.29"";""0.23"";""3.52"";""4.91"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5953094;"""";""None"";""528.52"";""1"";""1.22"";""BDBM500045"";""O=C1CCC(N2C(=O)c3cccc(NC(=O)CNC=C4C(=O)CC(c5ccccc5)CC4=O)c3C2=O)C(=O)N1"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1041943"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL5945996;"""";""None"";""487.51"";""0"";""2.47"";""BDBM500028"";""COc1ccc(C2CC(=O)C(=CNc3cccc4c3CN(C3CCC(=O)NC3=O)C4=O)C(=O)C2)cc1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041926"";""UO_0000065"";""12.56"";""0.23"";""3.65"";""5.03"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5819372;"""";""None"";""542.59"";""1"";""2.35"";""BDBM500040"";""C[C@@H](CC(=O)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O)NC=C1C(=O)CC(c2ccccc2)CC1=O"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1041938"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL6023979;"""";""None"";""621.61"";""1"";""3.24"";""BDBM500076"";""O=C1CCC(N2C(=O)c3cccc(NC(=O)OCc4ccc(NC=C5C(=O)CC(c6ccccc6)CC5=O)nc4)c3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041974"";""UO_0000065"";""9.85"";""0.18"";""2.88"";""3.39"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5884677;"""";""None"";""668.75"";""1"";""1.50"";""BDBM500084"";""O=C1CCC(N2Cc3c(NC(=O)CCC(=O)N4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041982"";""UO_0000065"";""9.81"";""0.18"";""5.06"";""3.97"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL6006975;"""";""None"";""715.76"";""2"";""1.43"";""BDBM500092"";""O=C1CCC(N2C(=O)c3cccc(OC(=O)OCCOCCN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)c3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041990"";""UO_0000065"";""9.17"";""0.17"";""5.13"";""3.63"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL6028306;"""";""None"";""626.71"";""1"";""1.31"";""BDBM500097"";""O=C1CCC(N2C(=O)c3cccc(NCCN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)c3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041995"";""UO_0000065"";""10.47"";""0.19"";""5.25"";""4.43"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5892242;"""";""None"";""464.50"";""0"";""1.92"";""BDBM500099"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5nccs5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041997"";""UO_0000065"";""14.12"";""0.27"";""4.64"";""5.23"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5842023;"""";""None"";""459.46"";""0"";""2.00"";""BDBM500100"";""O=C1CCC(N2Cc3c(N/C=C4\C(=O)CC(c5ccccc5)OC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041998"";""UO_0000065"";""14.28"";""0.26"";""4.56"";""5.38"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL6048412;"""";""None"";""508.53"";""1"";""3.01"";""BDBM500101"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ccnc6ccccc56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041999"";""UO_0000065"";""12.04"";""0.22"";""3.11"";""4.88"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5781498;"""";""None"";""534.57"";""1"";""3.52"";""BDBM500105"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ccc(-c6ccncc6)cc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042003"";""UO_0000065"";""12.27"";""0.22"";""3.04"";""5.23"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5748774;"""";""None"";""558.59"";""1"";""1.59"";""BDBM500044"";""O=C1CCC(N2Cc3c(NC(=O)COCCNC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1041942"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL5846793;"""";""None"";""457.49"";""0"";""2.14"";""BDBM500109"";""O=C1CCC(N2Cc3c(N/C=C4\C(=O)CC(Cc5ccccc5)C4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042007"";""UO_0000065"";""14.34"";""0.26"";""4.42"";""5.82"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5921411;"""";""None"";""611.66"";""1"";""1.73"";""BDBM500089"";""O=C1CC(c2ccccc2)CC(=O)C1=CNCCN1CCN(C(=O)N2C(=O)CCC(N3C(=O)c4ccccc4C3=O)C2=O)CC1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041987"";""UO_0000065"";""10.73"";""0.20"";""4.83"";""4.54"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5876621;"""";""None"";""641.68"";""1"";""0.80"";""BDBM500093"";""O=C1CCC(N2C(=O)c3cccc(OCC(=O)N4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)c3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041991"";""UO_0000065"";""10.22"";""0.19"";""5.76"";""4.04"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5556033;"""";""None"";""271.36"";""0"";""2.89"";""LC3in-C8"";""CCCNC=C1C(=O)CC(c2ccc(C)cc2)CC1=O"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL5566567;"""";""None"";""273.33"";""0"";""1.48"";""LC3in-C12"";""Cc1ccc(C2CC(=O)C(=CNCCO)C(=O)C2)cc1"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL6047488;"""";""None"";""719.59"";""1"";""1.60"";""BDBM500145"";""O=C1CCC(N2C(=O)c3cccc(NC(=O)CN4CCN(CCNC=C5C(=O)CC(c6ccccc6Br)CC5=O)CC4)c3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042043"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5866926;"""";""None"";""612.69"";""1"";""1.67"";""BDBM500088"";""Nc1cccc2c1CN(C1CCC(=O)N(C(=O)N3CCN(CCNC=C4C(=O)CC(c5ccccc5)CC4=O)CC3)C1=O)C2=O"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041986"";""UO_0000065"";""10.71"";""0.20"";""4.89"";""4.28"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5983228;"""";""None"";""612.73"";""1"";""1.67"";""BDBM500095"";""O=C1CCC(N2Cc3c(NCCN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041993"";""UO_0000065"";""10.71"";""0.20"";""4.89"";""5.00"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5751528;"""";""None"";""487.51"";""0"";""2.37"";""BDBM500106"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(COc5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042004"";""UO_0000065"";""13.46"";""0.25"";""4.19"";""5.38"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5802551;"""";""None"";""480.48"";""0"";""2.73"";""BDBM500126"";""O=C1CCC(N2Cc3c(N/C=C4\C(=O)Nc5c(ccc6ccccc56)C4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1042024"";""UO_0000065"";""12.75"";""0.23"";""3.39"";""4.91"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5983684;"""";""None"";""577.92"";""1"";""4.27"";""BDBM500130"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5c(C(F)(F)F)ccc(Cl)c5F)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042028"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL2172255;"""";""None"";""273.29"";""0"";""1.26"";""BDBM584988"";""O=C(O)CNC=C1C(=O)CC(c2ccccc2)CC1=O"";""IC50"";""'='"";""57500.0"";""nM"";""4.24"";"""";""1230224"";""UO_0000065"";""15.52"";""0.29"";""2.98"";""5.08"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""57500.0"""
"CHEMBL6040284;"""";""None"";""195.26"";""0"";""1.39"";""BDBM584990"";""CCC1CC(=O)C(=CN(C)C)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230226"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5558068;"""";""None"";""341.45"";""0"";""3.30"";""LC3in-C4"";""Cc1ccc(C2CC(=O)C(=CNCCC3CCOCC3)C(=O)C2)cc1"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL5563779;"""";""None"";""314.39"";""0"";""1.62"";""LC3in-C11"";""CC(=O)NCCNC=C1C(=O)CC(c2ccc(C)cc2)CC1=O"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL5562113;"""";""None"";""365.27"";""0"";""2.50"";""LC3in-C30"";""CN(C)CCNC=C1C(=O)CC(c2cccc(Br)c2)CC1=O"";""IC50"";""'='"";""490.0"";""nM"";""6.31"";"""";"""";""UO_0000065"";""17.27"";""0.39"";""3.81"";""12.77"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.49""",,,,,,,,
"CHEMBL5542635;"""";""None"";""224.30"";""0"";""0.59"";""LC3in-D1"";""CC1CC(=O)C(=CNCCN(C)C)C(=O)C1"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL5556385;"""";""None"";""394.30"";""0"";""3.53"";""LC3in-C42"";""CN(C)CCNC=C1C(=O)CC(c2c(Cl)c(Cl)cc3[nH]ccc23)CC1=O"";""IC50"";""'='"";""56.46"";""nM"";""7.25"";"""";"""";""UO_0000065"";""18.38"";""0.38"";""3.72"";""11.12"";""0"";""CHEMBL5526719"";""Inhibition of GST-tagged LC3B K49R mutant (unknown origin) using biotin-labeled LBP2 as substrate preincubated with compound for 12 hrs followed by substrate addition and measured after 2 hrs by Alphascreen assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";""Q9GZQ8"";""K49R"";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 14.0 hr"";""INHIBITOR"";"""";""56.46""",,,,,,,,
"CHEMBL5565533;"""";""None"";""341.46"";""0"";""1.39"";""LC3in-C2"";""Cc1ccc(C2CC(=O)C(=CNCCN3CCNCC3)C(=O)C2)cc1"";""IC50"";""'='"";""6800.0"";""nM"";""5.17"";"""";"""";""UO_0000065"";""15.13"";""0.28"";""3.78"";""8.41"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""6.8""",,,,,,,,
"CHEMBL5560134;"""";""None"";""340.47"";""0"";""2.97"";""LC3in-C5"";""Cc1ccc(C2CC(=O)C(=CNCCN3CCCCC3)C(=O)C2)cc1"";""IC50"";""'='"";""1210.0"";""nM"";""5.92"";"""";"""";""UO_0000065"";""17.38"";""0.32"";""2.95"";""11.98"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""1.21""",,,,,,,,
"CHEMBL5560550;"""";""None"";""271.36"";""0"";""2.89"";""LC3in-C6"";""Cc1ccc(C2CC(=O)C(=CNC(C)C)C(=O)C2)cc1"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL5561990;"""";""None"";""314.43"";""0"";""2.44"";""LC3in-C15"";""Cc1ccc(C2CC(=O)C(=CNCCCN(C)C)C(=O)C2)cc1"";""IC50"";""'='"";""7770.0"";""nM"";""5.11"";"""";"""";""UO_0000065"";""16.25"";""0.30"";""2.67"";""10.34"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""7.77""",,,,,,,,
"CHEMBL5561269;"""";""None"";""316.40"";""0"";""1.75"";""LC3in-C20"";""COc1ccccc1C1CC(=O)C(=CNCCN(C)C)C(=O)C1"";""IC50"";""'='"";""1660.0"";""nM"";""5.78"";"""";"""";""UO_0000065"";""18.27"";""0.34"";""4.03"";""9.86"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""1.66""",,,,,,,,
"CHEMBL5568388;"""";""None"";""304.36"";""0"";""1.88"";""LC3in-C23"";""CN(C)CCNC=C1C(=O)CC(c2ccccc2F)CC1=O"";""IC50"";""'='"";""440.0"";""nM"";""6.36"";"""";"""";""UO_0000065"";""20.88"";""0.39"";""4.48"";""12.86"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.44""",,,,,,,,
"CHEMBL5564981;"""";""None"";""320.82"";""0"";""2.39"";""LC3in-C28"";""CN(C)CCNC=C1C(=O)CC(c2ccc(Cl)cc2)CC1=O"";""IC50"";""'='"";""940.0"";""nM"";""6.03"";"""";"""";""UO_0000065"";""18.79"";""0.37"";""3.64"";""12.20"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.94""",,,,,,,,
"CHEMBL5557502;"""";""None"";""365.27"";""0"";""2.50"";""LC3in-C29"";""CN(C)CCNC=C1C(=O)CC(c2ccccc2Br)CC1=O"";""IC50"";""'='"";""300.0"";""nM"";""6.52"";"""";"""";""UO_0000065"";""17.86"";""0.40"";""4.02"";""13.20"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.3""",,,,,,,,
"CHEMBL5565069;"""";""None"";""389.71"";""0"";""3.70"";""LC3in-C36"";""CN(C)CCNC=C1C(=O)CC(c2cc(Cl)cc(Cl)c2Cl)CC1=O"";""IC50"";""'='"";""220.0"";""nM"";""6.66"";"""";"""";""UO_0000065"";""17.08"";""0.38"";""2.96"";""13.47"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.22""",,,,,,,,
"CHEMBL5556385;"""";""None"";""394.30"";""0"";""3.53"";""LC3in-C42"";""CN(C)CCNC=C1C(=O)CC(c2c(Cl)c(Cl)cc3[nH]ccc23)CC1=O"";""IC50"";""'='"";""7.6"";""nM"";""8.12"";"""";"""";""UO_0000065"";""20.59"";""0.43"";""4.59"";""12.45"";""0"";""CHEMBL5526713"";""Inhibition of GST-tagged LC3B (unknown origin) using biotin-labeled LBP2 as substrate preincubated with compound for 12 hrs followed by substrate addition and measured after 2 hrs by Alphascreen assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 14.0 hr"";""INHIBITOR"";"""";""7.6""",,,,,,,,
"CHEMBL5556385;"""";""None"";""394.30"";""0"";""3.53"";""LC3in-C42"";""CN(C)CCNC=C1C(=O)CC(c2c(Cl)c(Cl)cc3[nH]ccc23)CC1=O"";""IC50"";""'='"";""17.4"";""nM"";""7.76"";"""";"""";""UO_0000065"";""19.68"";""0.41"";""4.23"";""11.90"";""0"";""CHEMBL5526718"";""Inhibition of GST-tagged wild type LC3B (unknown origin) using biotin-labeled LBP2 as substrate preincubated with compound for 12 hrs followed by substrate addition and measured after 2 hrs by Alphascreen assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 14.0 hr"";""INHIBITOR"";"""";""17.4""",,,,,,,,
"CHEMBL4864988;"""";""None"";""408.45"";""0"";""4.30"";""14r"";""CC(=O)Nc1ccc2c(O)c(NC(=O)c3cccc(CCC(C)C)c3)c(=O)oc2c1"";""IC50"";""'='"";""223000.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""223.0""",,,,,,,,
"CHEMBL4853160;"""";""None"";""385.39"";""0"";""4.18"";""10"";""CC(C)CCc1cc(C(=O)Nc2c(O)c3ccc(O)cc3oc2=O)ccc1F"";""IC50"";""'='"";""172000.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""172.0""",,,,,,,,
"CHEMBL4865705;"""";""None"";""367.40"";""0"";""4.05"";""12"";""CC(C)CCc1ccccc1C(=O)Nc1c(O)c2ccc(O)cc2oc1=O"";""IC50"";""'='"";""347600.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""347.6""",,,,,,,,
"CHEMBL4877022;"""";""None"";""350.33"";""0"";""1.67"";""13a"";""CC(C)(C)OC(=O)NCC(=O)Nc1c(O)c2ccc(O)cc2oc1=O"";""IC50"";"""";"""";"""";"""";"""";""Not Active"";"""";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";"""";"""";""""",,,,,,,,
"CHEMBL4878621;"""";""None"";""534.63"";""2"";""5.32"";""14i"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(NS(=O)(=O)CCc4ccccc4)cc3oc2=O)c1"";""IC50"";""'='"";""66300.0"";""nM"";""4.18"";"""";"""";""UO_0000065"";""7.82"";""0.15"";""-1.14"";""3.32"";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""66.3""",,,,,,,,
"CHEMBL4859492;"""";""None"";""520.61"";""2"";""5.28"";""14j"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(NS(=O)(=O)Cc4ccccc4)cc3oc2=O)c1"";""IC50"";""'='"";""119900.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""119.9""",,,,,,,,
"CHEMBL5794708;"""";""None"";""526.38"";""1"";""3.77"";""BDBM499998"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5cccc(Cl)c5Cl)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041901"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL6018813;"""";""None"";""559.93"";""1"";""4.13"";""BDBM500132"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5cc(C(F)(F)F)ccc5Cl)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042030"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5794899;"""";""None"";""471.51"";""0"";""2.77"";""BDBM499995"";""Cc1ccccc1C1CC(=O)C(=CNc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)C(=O)C1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041898"";""UO_0000065"";""12.99"";""0.24"";""3.35"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5819842;"""";""None"";""475.48"";""0"";""2.60"";""BDBM500015"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ccc(F)cc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041913"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL6029702;"""";""None"";""463.52"";""0"";""2.52"";""BDBM500032"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5cccs5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041930"";""UO_0000065"";""13.21"";""0.25"";""3.60"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5793816;"""";""None"";""514.51"";""1"";""3.08"";""BDBM500037"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5c[nH]c6cccc(F)c56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041935"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5780106;"""";""None"";""576.61"";""1"";""3.71"";""BDBM500046"";""O=C1CCC(N2Cc3c(NC(=O)c4ccc(NC=C5C(=O)CC(c6ccccc6)CC5=O)cc4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041944"";""UO_0000065"";""11.38"";""0.21"";""2.85"";""4.63"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL1523484;"""";""None"";""305.38"";""0"";""3.38"";""BDBM584984"";""O=C1CC(c2ccccc2)CC(=O)C1=CNCc1ccccc1"";""IC50"";""'='"";""57500.0"";""nM"";""4.24"";"""";""1230220"";""UO_0000065"";""13.89"";""0.25"";""0.86"";""9.18"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""57500.0"""
"CHEMBL5746910;"""";""None"";""471.51"";""0"";""2.85"";""BDBM500112"";""O=C1CCC(N2Cc3c(N/C=C4\C(=O)CCC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042010"";""UO_0000065"";""13.91"";""0.26"";""3.71"";""5.82"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL6043571;"""";""None"";""515.55"";""1"";""2.46"";""BDBM500118"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ncnc6sccc56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042016"";""UO_0000065"";""12.73"";""0.24"";""4.10"";""4.74"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL6038043;"""";""None"";""744.89"";""2"";""1.72"";""BDBM500121"";""O=C1CCC(N2Cc3c(NCCOCCOCCOCCN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042019"";""UO_0000065"";""8.81"";""0.17"";""4.84"";""4.13"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5986633;"""";""None"";""496.52"";""0"";""2.60"";""BDBM500127"";""CC1(C#N)C(=O)/C(=C/Nc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)C(=O)CC1c1ccccc1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1042025"";""UO_0000065"";""12.34"";""0.23"";""3.52"";""4.49"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5745020;"""";""None"";""594.37"";""1"";""4.78"";""BDBM500129"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5c(C(F)(F)F)ccc(Cl)c5Cl)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042027"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5989874;"""";""None"";""777.58"";""1"";""3.16"";""BDBM500146"";""O=C1CCC(N2C(=O)c3cccc(NC(=O)CN4CCN(CCNC=C5C(=O)CC(c6c(Cl)ccc(C(F)(F)F)c6Cl)CC5=O)CC4)c3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042044"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5916198;"""";""None"";""576.61"";""1"";""3.71"";""BDBM500049"";""O=C1CCC(N2Cc3c(NC(=O)c4cccc(NC=C5C(=O)CC(c6ccccc6)CC5=O)c4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041947"";""UO_0000065"";""11.38"";""0.21"";""2.85"";""4.63"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5745959;"""";""None"";""662.73"";""1"";""0.55"";""BDBM500064"";""O=C1CCC(N2C(=O)c3cccc(NS(=O)(=O)N4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)c3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041962"";""UO_0000065"";""9.24"";""0.18"";""5.57"";""3.36"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5803551;"""";""None"";""540.36"";""1"";""3.41"";""BDBM499997"";""O=C1CCC(N2C(=O)c3cccc(NC=C4C(=O)CC(c5cccc(Cl)c5Cl)CC4=O)c3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041900"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5942336;"""";""None"";""643.42"";""1"";""4.72"";""BDBM500012"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5c(Br)ccc6[nH]cc(C(F)(F)F)c56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041910"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5888705;"""";""None"";""525.48"";""1"";""3.48"";""BDBM500017"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ccc(C(F)(F)F)cc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041915"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5879834;"""";""None"";""514.54"";""1"";""1.58"";""BDBM500038"";""O=C1CCC(N2Cc3c(NC(=O)CNC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1041936"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL5740588;"""";""None"";""712.80"";""2"";""1.52"";""BDBM500052"";""O=C1CCC(N2Cc3c(NC(=O)CCC(=O)OCCN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041950"";""UO_0000065"";""8.59"";""0.16"";""4.60"";""3.51"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL6061309;"""";""None"";""568.59"";""1"";""2.73"";""BDBM500021"";""CCOC(=O)C1C(=O)/C(=C/Nc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)C(=O)CC1c1cccc2[nH]ccc12"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041919"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5996316;"""";""None"";""475.48"";""0"";""2.41"";""BDBM500024"";""O=C1CCC(N2Cc3c(N/C=C4\C(=O)CC(c5ccccc5)C(F)C4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041922"";""UO_0000065"";""12.88"";""0.24"";""3.71"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL600635;"""";""None"";""254.24"";""0"";""2.87"";""AN2"";""O=c1cc(-c2ccccc2)c2c(O)cc(O)cc2o1"";""IC50"";""'='"";""200.0"";""nM"";""6.70"";"""";"""";""UO_0000065"";""26.35"";""0.48"";""3.83"";""9.48"";""0"";""CHEMBL5506219"";""Inhibition of human LC3B expressed in Escherichia coli BL21 (DE3)"";""B"";""BAO_0000019"";""assay format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5505953"";""1"";""Scientific Literature"";""Eur J Med Chem"";""2024"";""None"";"""";""INHIBITOR"";"""";""0.2""",,,,,,,,
"CHEMBL5285058;"""";""None"";""411.05"";""0"";""4.12"";""AN1"";""O=C1Nc2ccc(Br)cc2/C1=C/c1cc(O)c(O)c(Br)c1"";""IC50"";""'='"";""200.0"";""nM"";""6.70"";"""";"""";""UO_0000065"";""16.30"";""0.44"";""2.58"";""9.63"";""0"";""CHEMBL5506219"";""Inhibition of human LC3B expressed in Escherichia coli BL21 (DE3)"";""B"";""BAO_0000019"";""assay format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5505953"";""1"";""Scientific Literature"";""Eur J Med Chem"";""2024"";""None"";"""";""INHIBITOR"";"""";""0.2""",,,,,,,,
"CHEMBL5812007;"""";""None"";""610.67"";""1"";""2.23"";""BDBM500090"";""O=C1CC(c2ccccc2)CC(=O)C1=CNCCN1CCC(C(=O)N2C(=O)CCC(N3C(=O)c4ccccc4C3=O)C2=O)CC1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041988"";""UO_0000065"";""10.74"";""0.20"";""4.33"";""4.65"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5830071;"""";""None"";""458.47"";""0"";""1.40"";""BDBM500107"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CN(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042005"";""UO_0000065"";""14.31"";""0.26"";""5.16"";""5.66"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5855063;"""";""None"";""483.52"";""0"";""3.01"";""BDBM500108"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(/C=C/c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042006"";""UO_0000065"";""13.57"";""0.25"";""3.55"";""5.82"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5840497;"""";""None"";""471.51"";""0"";""2.71"";""BDBM500115"";""CC1C(=O)/C(=C/Nc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)C(=O)CC1c1ccccc1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1042013"";""UO_0000065"";""12.99"";""0.24"";""3.41"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL4854132;"""";""None"";""520.61"";""2"";""5.45"";""14n"";""Cc1ccccc1S(=O)(=O)Nc1ccc2c(O)c(NC(=O)c3cccc(CCC(C)C)c3)c(=O)oc2c1"";""IC50"";""'='"";""97600.0"";""nM"";""4.01"";"""";"""";""UO_0000065"";""7.70"";""0.15"";""-1.44"";""3.19"";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""97.6""",,,,,,,,
"CHEMBL4852281;"""";""None"";""556.64"";""2"";""6.29"";""14o"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(NS(=O)(=O)c4cccc5ccccc45)cc3oc2=O)c1"";""IC50"";""'='"";""37300.0"";""nM"";""4.43"";"""";"""";""UO_0000065"";""7.96"";""0.15"";""-1.86"";""3.52"";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""37.3""",,,,,,,,
"CHEMBL36506;""NOVOBIOCIN"";""4.0"";""612.63"";""2"";""3.63"";""1"";""CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C"";""IC50"";""'='"";""172000.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""172.0""",,,,,,,,
"CHEMBL4867343;"""";""None"";""406.44"";""0"";""3.08"";""13e"";""CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)Nc1c(O)c2ccc(O)cc2oc1=O"";""IC50"";""'='"";""410600.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""410.6""",,,,,,,,
"CHEMBL4861964;"""";""None"";""471.51"";""1"";""5.70"";""14d"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(-c4cccc(C(=O)O)c4)cc3oc2=O)c1"";""IC50"";""'='"";""131700.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""131.7""",,,,,,,,
"CHEMBL4866902;"""";""None"";""467.52"";""1"";""6.75"";""14e"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(-c4coc5ccccc45)cc3oc2=O)c1"";""IC50"";"""";"""";"""";"""";"""";""Not Active"";"""";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";"""";"""";""""",,,,,,,,
"CHEMBL4864565;"""";""None"";""486.59"";""0"";""4.74"";""14k"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(NS(=O)(=O)CC(C)C)cc3oc2=O)c1"";""IC50"";""'='"";""175500.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""175.5""",,,,,,,,
"CHEMBL5885276;"""";""None"";""357.45"";""0"";""1.09"";""BDBM585024"";""COc1ccc(C2CC(=O)C(=CNCCN3CCNCC3)C(=O)C2)cc1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230260"";""UO_0000065"";""14.12"";""0.27"";""3.96"";""7.14"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL1872419;"""";""None"";""383.54"";""0"";""2.28"";""BDBM585028"";""CC1(C)CC(=O)C(=CNCCN2CCN(CCc3ccccc3)CC2)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230264"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5862910;"""";""None"";""415.53"";""0"";""2.49"";""BDBM76261"";""CCCCCC(=O)N1CCN(CCNC=C2C(=O)CC(c3ccco3)CC2=O)CC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230266"";""UO_0000065"";""12.14"";""0.23"";""2.56"";""6.09"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL1905947;"""";""None"";""342.44"";""0"";""1.90"";""BDBM585032"";""O=C1CC(c2ccccc2)CC(=O)C1=CNCCCN1CCOCC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230268"";""UO_0000065"";""14.73"";""0.28"";""3.15"";""8.60"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL5765884;"""";""None"";""299.33"";""0"";""2.72"";""BDBM585033"";""O=c1c(=CNc2ccccc2)c(=O)c2cccc3cccc1c32"";""IC50"";""'='"";""57500.0"";""nM"";""4.24"";"""";""1230269"";""UO_0000065"";""14.17"";""0.25"";""1.52"";""9.18"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""57500.0"""
"CHEMBL5852403;"""";""None"";""415.51"";""0"";""1.94"";""BDBM585018"";""CC1(C)CC(=O)C(=CNCCN2CCN(C(=O)Cc3ccc(F)cc3)CC2)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230254"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5995196;"""";""None"";""193.25"";""0"";""1.14"";""BDBM584994"";""CN(C)C=C1C(=O)CC2(CC2)CC1=O"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230230"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL1537323;"""";""None"";""464.54"";""0"";""3.16"";""BDBM585004"";""O=C1CC(c2ccc(F)cc2)CC(=O)C1=CNCCN1CCN(C(=O)Nc2ccccc2)CC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230240"";""UO_0000065"";""10.86"";""0.20"";""1.89"";""6.17"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL4877483;"""";""None"";""406.44"";""0"";""3.08"";""13d"";""CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1c(O)c2ccc(O)cc2oc1=O"";""IC50"";"""";"""";"""";"""";"""";""Not Active"";"""";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";"""";"""";""""",,,,,,,,
"CHEMBL4850512;"""";""None"";""503.60"";""2"";""7.67"";""14b"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(-c4ccccc4-c4ccccc4)cc3oc2=O)c1"";""IC50"";"""";"""";"""";"""";"""";""Not Active"";"""";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";"""";"""";""""",,,,,,,,
"CHEMBL4875883;"""";""None"";""506.58"";""2"";""5.14"";""14l"";""CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc(NS(=O)(=O)c4ccccc4)cc3oc2=O)c1"";""IC50"";""'='"";""123000.0"";""nM"";"""";""Outside typical range"";"""";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL4835350"";""Displacement of sGFP-p62-LIR peptide from human N-terminal SNAP-fused LC3B by time-resolved FRET assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL4834414"";""1"";""Scientific Literature"";""J Med Chem"";""2021"";""None"";"""";""BINDING AGENT"";"""";""123.0""",,,,,,,,
"CHEMBL5566487;"""";""None"";""287.36"";""0"";""2.13"";""LC3in-C13"";""COCCNC=C1C(=O)CC(c2ccc(C)cc2)CC1=O"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL5560956;"""";""None"";""325.41"";""0"";""2.22"";""LC3in-C41"";""CN(C)CCNC=C1C(=O)CC(c2cccc3[nH]ccc23)CC1=O"";""IC50"";""'='"";""440.0"";""nM"";""6.36"";"""";"""";""UO_0000065"";""19.53"";""0.36"";""4.14"";""9.75"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.44""",,,,,,,,
"CHEMBL5556385;"""";""None"";""394.30"";""0"";""3.53"";""LC3in-C42"";""CN(C)CCNC=C1C(=O)CC(c2c(Cl)c(Cl)cc3[nH]ccc23)CC1=O"";""IC50"";""'='"";""80.0"";""nM"";""7.10"";"""";"""";""UO_0000065"";""18.00"";""0.37"";""3.57"";""10.88"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.08""",,,,,,,,
"CHEMBL5560804;"""";""None"";""355.26"";""0"";""3.04"";""LC3in-C32"";""CN(C)CCNC=C1C(=O)CC(c2cccc(Cl)c2Cl)CC1=O"";""IC50"";""'='"";""33.6"";""nM"";""7.47"";"""";"""";""UO_0000065"";""21.04"";""0.44"";""4.43"";""15.13"";""0"";""CHEMBL5526713"";""Inhibition of GST-tagged LC3B (unknown origin) using biotin-labeled LBP2 as substrate preincubated with compound for 12 hrs followed by substrate addition and measured after 2 hrs by Alphascreen assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 14.0 hr"";""INHIBITOR"";"""";""33.6""",,,,,,,,
"CHEMBL5563109;"""";""None"";""397.30"";""0"";""2.81"";""D5; DC-LC3in-D5"";""O=C1CC(c2cccc(Cl)c2Cl)CC(=O)C1=CNCCN1CCOCC1"";""IC50"";""'='"";""51.7"";""nM"";""7.29"";"""";"""";""UO_0000065"";""18.34"";""0.38"";""4.48"";""12.43"";""0"";""CHEMBL5526713"";""Inhibition of GST-tagged LC3B (unknown origin) using biotin-labeled LBP2 as substrate preincubated with compound for 12 hrs followed by substrate addition and measured after 2 hrs by Alphascreen assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 14.0 hr"";""INHIBITOR"";"""";""51.7""",,,,,,,,
"CHEMBL5815465;"""";""None"";""577.60"";""1"";""3.11"";""BDBM500062"";""O=C1CCC(N2Cc3c(NC(=O)c4ccc(NC=C5C(=O)CC(c6ccccc6)CC5=O)nc4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041960"";""UO_0000065"";""11.36"";""0.21"";""3.45"";""4.24"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5992830;"""";""None"";""577.60"";""1"";""3.11"";""BDBM500063"";""O=C1CCC(N2Cc3c(NC(=O)c4cccnc4NC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041961"";""UO_0000065"";""10.60"";""0.19"";""3.01"";""3.96"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5561936;"""";""None"";""355.27"";""0"";""3.04"";""LC3in-C33"";""CN(C)CCNC=C1C(=O)CC(c2cc(Cl)ccc2Cl)CC1=O"";""IC50"";""'='"";""400.0"";""nM"";""6.40"";"""";"""";""UO_0000065"";""18.01"";""0.38"";""3.36"";""12.95"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.4""",,,,,,,,
"CHEMBL5532454;"""";""None"";""276.34"";""0"";""1.33"";""LC3in-C40"";""CN(C)CCNC=C1C(=O)CC(c2ccco2)CC1=O"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL6030071;"""";""None"";""277.75"";""0"";""2.80"";""BDBM584977"";""CN(C)C=C1C(=O)CC(c2ccc(Cl)cc2)CC1=O"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230213"";""UO_0000065"";""18.17"";""0.36"";""2.25"";""13.50"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL5959859;"""";""None"";""273.33"";""0"";""2.16"";""BDBM584978"";""COc1ccccc1C1CC(=O)C(=CN(C)C)C(=O)C1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230214"";""UO_0000065"";""18.46"";""0.34"";""2.89"";""10.83"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL5812425;"""";""None"";""582.57"";""1"";""2.37"";""BDBM500022"";""CCOC(=O)C1C(=O)/C(=C/Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)C(=O)CC1c1cccc2[nH]ccc12"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041920"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5563769;"""";""None"";""339.48"";""0"";""4.45"";""LC3in-C3"";""Cc1ccc(C2CC(=O)C(=CNCCC3CCCCC3)C(=O)C2)cc1"";""IC50"";"""";"""";"""";"""";"""";""Not Determined"";"""";"""";"""";"""";"""";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";"""";"""";""""",,,,,,,,
"CHEMBL5563109;"""";""None"";""397.30"";""0"";""2.81"";""D5; DC-LC3in-D5"";""O=C1CC(c2cccc(Cl)c2Cl)CC(=O)C1=CNCCN1CCOCC1"";""IC50"";""'='"";""140.0"";""nM"";""6.85"";"""";"""";""UO_0000065"";""17.25"";""0.36"";""4.04"";""11.69"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.14""",,,,,,,,
"CHEMBL5567305;"""";""None"";""292.42"";""0"";""2.15"";""LC3in-C37"";""CN(C)CCNC=C1C(=O)CC(C2CCCCC2)CC1=O"";""IC50"";""'='"";""8140.0"";""nM"";""5.09"";"""";"""";""UO_0000065"";""17.40"";""0.33"";""2.94"";""10.30"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""8.14""",,,,,,,,
"CHEMBL5878357;"""";""None"";""473.49"";""0"";""2.16"";""BDBM500030"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ccc(O)cc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041928"";""UO_0000065"";""12.94"";""0.24"";""3.96"";""4.61"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5568228;"""";""None"";""292.40"";""0"";""1.80"";""LC3in-C39"";""CN(C)CCNC=C1C(=O)CC(c2cccs2)CC1=O"";""IC50"";""'='"";""2320.0"";""nM"";""5.63"";"""";"""";""UO_0000065"";""19.27"";""0.38"";""3.83"";""11.40"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""2.32""",,,,,,,,
"CHEMBL5556385;"""";""None"";""394.30"";""0"";""3.53"";""LC3in-C42"";""CN(C)CCNC=C1C(=O)CC(c2c(Cl)c(Cl)cc3[nH]ccc23)CC1=O"";""IC50"";""'='"";""17.4"";""nM"";""7.76"";"""";"""";""UO_0000065"";""19.68"";""0.41"";""4.23"";""11.90"";""0"";""CHEMBL5526723"";""Inhibition of LC3B (unknown origin) by Alphascreen assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";"""";""INHIBITOR"";"""";""17.4""",,,,,,,,
"CHEMBL5900051;"""";""None"";""512.44"";""1"";""2.62"";""BDBM500124"";""CN1C(=O)/C(=C\Nc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)C(=O)c2ccc(C(F)(F)F)cc21"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1042022"";""UO_0000065"";""11.95"";""0.23"";""3.50"";""5.29"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5910266;"""";""None"";""543.47"";""1"";""3.62"";""BDBM500128"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5cc(C(F)(F)F)ccc5F)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042026"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5846829;"""";""None"";""509.92"";""1"";""3.25"";""BDBM500135"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5c(F)cccc5Cl)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042033"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5981308;"""";""None"";""530.97"";""1"";""3.59"";""BDBM500139"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5cc6[nH]ccc6cc5Cl)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042037"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5743726;"""";""None"";""523.49"";""1"";""2.75"";""BDBM500141"";""COc1ccc(C2CC(=O)C(=CNc3cccc4c3CN(C3CCC(=O)NC3=O)C4=O)C(=O)C2)c(F)c1F"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042039"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5808954;"""";""None"";""514.54"";""1"";""2.42"";""BDBM500144"";""CC(=O)Nc1ccccc1C1CC(=O)C(=CNc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)C(=O)C1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042042"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5862727;"""";""None"";""590.64"";""1"";""4.02"";""BDBM500047"";""Cc1cc(C(=O)Nc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)ccc1NC=C1C(=O)CC(c2ccccc2)CC1=O"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041945"";""UO_0000065"";""11.11"";""0.20"";""2.54"";""4.63"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL6042038;"""";""None"";""607.62"";""1"";""3.60"";""BDBM500075"";""O=C1CCC(N2Cc3c(NC(=O)OCc4ccc(NC=C5C(=O)CC(c6ccccc6)CC5=O)nc4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041973"";""UO_0000065"";""10.08"";""0.19"";""2.52"";""3.74"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL6062477;"""";""None"";""1032.17"";""None"";""None"";""BDBM500083"";""CC(C)[C@H](NC(=O)CN1CCN(CCNC=C2C(=O)CC(c3ccccc3)CC2=O)CC1)C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(COC(=O)Nc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)cc1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041981"";""UO_0000065"";""6.36"";""None"";""None"";""None"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5909720;"""";""None"";""652.75"";""1"";""1.75"";""BDBM500086"";""O=C(/C=C\CN1CCN(CCNC=C2C(=O)CC(c3ccccc3)CC2=O)CC1)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041984"";""UO_0000065"";""10.05"";""0.19"";""4.81"";""4.43"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL6053052;"""";""None"";""453.45"";""0"";""0.85"";""BDBM500122"";""CCOC(=O)C1CC(=O)C(=CNc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)C(=O)C1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042020"";""UO_0000065"";""14.47"";""0.27"";""5.71"";""4.72"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5827617;"""";""None"";""534.96"";""1"";""2.58"";""BDBM500123"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(C(=O)Nc5ccc(Cl)cc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1042021"";""UO_0000065"";""11.45"";""0.22"";""3.54"";""4.32"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5870823;"""";""None"";""509.92"";""1"";""3.25"";""BDBM500134"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5cccc(Cl)c5F)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042032"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5924020;"""";""None"";""611.70"";""1"";""2.29"";""BDBM499992"";""O=C1CCC(N2Cc3c(NC(=O)C4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041895"";""UO_0000065"";""10.01"";""0.19"";""3.83"";""4.22"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL6057680;"""";""None"";""544.56"";""1"";""2.19"";""BDBM500071"";""O=C1CCC(N2Cc3c(NC(=O)OCCNC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041969"";""UO_0000065"";""12.05"";""0.22"";""4.37"";""4.35"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL6003912;"""";""None"";""847.93"";""2"";""3.13"";""BDBM500074"";""O=C1CCC(N2Cc3c(NC(=O)Nc4ccccc4OC(=O)CCC(=O)OCCN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041972"";""UO_0000065"";""7.74"";""0.14"";""3.43"";""3.08"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5799836;"""";""None"";""195.26"";""0"";""1.39"";""BDBM584993"";""CN(C)C=C1C(=O)CC(C)(C)CC1=O"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230229"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5853062;"""";""None"";""1118.26"";""None"";""None"";""BDBM500082"";""CC(C)[C@H](NC(=O)CCC(=O)OCCN1CCN(CCNC=C2C(=O)CC(c3ccccc3)CC2=O)CC1)C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(COC(=O)Nc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)cc1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041980"";""UO_0000065"";""5.87"";""None"";""None"";""None"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5863478;"""";""None"";""754.75"";""2"";""1.03"";""BDBM500079"";""O=C1CCC(N2C(=O)c3cccc(NC(=O)OCOC(=O)/C=C/C(=O)N4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)c3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041977"";""UO_0000065"";""8.69"";""0.16"";""5.53"";""3.01"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5955003;"""";""None"";""579.45"";""1"";""3.29"";""BDBM500027"";""CN(C)c1ccc(Br)c(C2CC(=O)C(=CNc3cccc4c3CN(C3CCC(=O)NC3=O)C4=O)C(=O)C2)c1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041925"";""UO_0000065"";""10.57"";""0.22"";""2.83"";""5.29"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5886759;"""";""None"";""515.52"";""1"";""2.25"";""BDBM500029"";""COC(=O)c1ccc(C2CC(=O)C(=CNc3cccc4c3CN(C3CCC(=O)NC3=O)C4=O)C(=O)C2)cc1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041927"";""UO_0000065"";""11.88"";""0.22"";""3.87"";""4.41"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL6048672;"""";""None"";""655.71"";""2"";""1.74"";""BDBM500091"";""O=C1CC(c2ccccc2)CC(=O)C1=CNCCN1CCN(CCOC(=O)N2C(=O)CCC(N3C(=O)c4ccccc4C3=O)C2=O)CC1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041989"";""UO_0000065"";""10.01"";""0.19"";""4.82"";""4.27"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL6031392;"""";""None"";""308.36"";""0"";""0.98"";""BDBM584998"";""Cc1ccc(S(=O)(=O)NNC=C2C(=O)CCCC2=O)cc1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230234"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5796470;"""";""None"";""536.38"";""1"";""3.22"";""BDBM500014"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ccccc5Br)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041912"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL6040381;"""";""None"";""457.49"";""0"";""2.46"";""BDBM500001"";""O=C1CCC(N2Cc3ccc(NC=C4C(=O)CC(c5ccccc5)CC4=O)cc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041904"";""UO_0000065"";""13.39"";""0.25"";""3.66"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5796325;"""";""None"";""554.37"";""1"";""3.36"";""BDBM500013"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ccc(F)cc5Br)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041911"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5892366;"""";""None"";""525.48"";""1"";""3.48"";""BDBM500019"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ccccc5C(F)(F)F)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041917"";""UO_0000065"";""11.66"";""0.22"";""2.64"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5950962;"""";""None"";""507.55"";""1"";""3.61"";""BDBM500025"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5cccc6ccccc56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041923"";""UO_0000065"";""12.07"";""0.22"";""2.51"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5741839;"""";""None"";""496.52"";""0"";""2.94"";""BDBM500034"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5c[nH]c6ccccc56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041932"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5986980;"""";""None"";""583.63"";""1"";""3.17"";""BDBM500058"";""O=C1CCC(N2Cc3c(NC(=O)c4cnc(NC=C5C(=O)CC(c6ccccc6)CC5=O)s4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041956"";""UO_0000065"";""10.49"";""0.20"";""2.95"";""3.96"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5953234;"""";""None"";""597.61"";""1"";""2.81"";""BDBM500059"";""O=C1CCC(N2C(=O)c3cccc(NC(=O)c4cnc(NC=C5C(=O)CC(c6ccccc6)CC5=O)s4)c3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041957"";""UO_0000065"";""10.25"";""0.19"";""3.31"";""3.57"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5994319;"""";""None"";""627.65"";""1"";""0.65"";""BDBM500060"";""O=C1CCC(N2C(=O)c3cccc(NC(=O)[C@@H]4C[C@H](O)CN4CCNC=C4C(=O)CC(c5ccccc5)CC4=O)c3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041958"";""UO_0000065"";""10.45"";""0.19"";""5.91"";""3.60"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5764459;"""";""None"";""648.74"";""1"";""0.91"";""BDBM500065"";""O=C1CCC(N2Cc3c(NS(=O)(=O)N4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041963"";""UO_0000065"";""10.11"";""0.19"";""5.65"";""3.97"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5988880;"""";""None"";""543.58"";""1"";""1.76"";""BDBM500070"";""O=C1CCC(N2Cc3c(NC(=O)NCCNC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041968"";""UO_0000065"";""12.07"";""0.22"";""4.80"";""4.27"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL6065218;"""";""None"";""656.74"";""1"";""1.80"";""BDBM500072"";""O=C1CCC(N2Cc3c(NC(=O)OCCN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041970"";""UO_0000065"";""9.99"";""0.19"";""4.76"";""4.17"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5909955;"""";""None"";""831.97"";""2"";""4.11"";""BDBM500081"";""CC(C)(CC(=O)OCCN1CCN(CCNC=C2C(=O)CC(c3ccccc3)CC2=O)CC1)c1ccccc1NC(=O)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041979"";""UO_0000065"";""7.89"";""0.15"";""2.45"";""3.52"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5818933;"""";""None"";""502.57"";""1"";""2.92"";""BDBM500104"";""CC(C)Cn1cccc1C1CC(=O)C(=CNc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)C(=O)C1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042002"";""UO_0000065"";""13.05"";""0.24"";""3.64"";""5.58"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5542425;"""";""None"";""286.38"";""0"";""1.74"";""LC3in-C17"";""CN(C)CCNC=C1C(=O)CC(c2ccccc2)CC1=O"";""IC50"";""'='"";""1260.0"";""nM"";""5.90"";"""";"""";""UO_0000065"";""20.60"";""0.38"";""4.16"";""11.94"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""1.26""",,,,,,,,
"CHEMBL5561472;"""";""None"";""300.40"";""0"";""2.05"";""LC3in-C19"";""Cc1cccc(C2CC(=O)C(=CNCCN(C)C)C(=O)C2)c1"";""IC50"";""'='"";""870.0"";""nM"";""6.06"";"""";"""";""UO_0000065"";""20.17"";""0.38"";""4.01"";""12.27"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.87""",,,,,,,,
"CHEMBL5560249;"""";""None"";""316.40"";""0"";""1.75"";""LC3in-C22"";""COc1ccc(C2CC(=O)C(=CNCCN(C)C)C(=O)C2)cc1"";""IC50"";""'='"";""1850.0"";""nM"";""5.73"";"""";"""";""UO_0000065"";""18.12"";""0.34"";""3.98"";""9.78"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""1.85""",,,,,,,,
"CHEMBL5556890;"""";""None"";""304.36"";""0"";""1.88"";""LC3in-C25"";""CN(C)CCNC=C1C(=O)CC(c2ccc(F)cc2)CC1=O"";""IC50"";""'='"";""1260.0"";""nM"";""5.90"";"""";"""";""UO_0000065"";""19.38"";""0.37"";""4.02"";""11.94"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""1.26""",,,,,,,,
"CHEMBL5560611;"""";""None"";""320.82"";""0"";""2.39"";""LC3in-C26"";""CN(C)CCNC=C1C(=O)CC(c2ccccc2Cl)CC1=O"";""IC50"";""'='"";""290.0"";""nM"";""6.54"";"""";"""";""UO_0000065"";""20.38"";""0.41"";""4.15"";""13.23"";""0"";""CHEMBL5526712"";""Inhibition of N-terminal GST-tagged LC3B (unknown origin) measured for 18 hrs by fluorescence polarization assay"";""B"";""BAO_0000357"";""single protein format"";""Homo sapiens"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5523753"";""1"";""Scientific Literature"";""J Med Chem"";""2024"";""None"";""TIME = 18.0 hr"";""INHIBITOR"";"""";""0.29""",,,,,,,,
"CHEMBL5829515;"""";""None"";""466.49"";""0"";""0.82"";""BDBM500102"";""CCCNC(=O)C1CC(=O)C(=CNc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)C(=O)C1"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1042000"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL5845251;"""";""None"";""509.92"";""1"";""3.25"";""BDBM500133"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ccc(Cl)cc5F)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042031"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5885054;"""";""None"";""578.81"";""1"";""4.56"";""BDBM500142"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5c(F)c(Cl)cc(Cl)c5Cl)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1042040"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5920411;"""";""None"";""528.57"";""1"";""1.97"";""BDBM500041"";""O=C1CCC(N2Cc3c(NC(=O)CCNC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1041939"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL3191721;"""";""None"";""389.52"";""0"";""1.79"";""BDBM585020"";""CCC(=O)N1CCN(CCNC=C2C(=O)CC(c3cccs3)CC2=O)CC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230256"";""UO_0000065"";""12.95"";""0.26"";""3.26"";""7.24"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL1362626;"""";""None"";""317.39"";""0"";""0.67"";""BDBM585007"";""O=C1CC(c2ccco2)CC(=O)C1=CNCCN1CCNCC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230243"";""UO_0000065"";""15.90"";""0.30"";""4.38"";""6.77"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL6035957;"""";""None"";""387.48"";""0"";""1.10"";""BDBM585016"";""COc1ccc(C2CC(=O)C(=CNCCN3CCNCC3)C(=O)C2)cc1OC"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230252"";""UO_0000065"";""13.02"";""0.25"";""3.95"";""6.32"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL5956153;"""";""None"";""459.59"";""0"";""2.87"";""BDBM585017"";""Cc1ccc(C2CC(=O)C(=CNCCN3CCN(C(=O)Cc4ccccc4)CC3)C(=O)C2)cc1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230253"";""UO_0000065"";""10.98"";""0.20"";""2.18"";""7.24"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL1391231;"""";""None"";""333.46"";""0"";""1.14"";""BDBM585021"";""O=C1CC(c2cccs2)CC(=O)C1=CNCCN1CCNCC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230257"";""UO_0000065"";""15.13"";""0.30"";""3.91"";""8.21"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL6054605;"""";""None"";""397.52"";""0"";""1.80"";""BDBM585025"";""CC1(C)CC(=O)C(=CNCCN2CCN(C(=O)Cc3ccccc3)CC2)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230261"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL1452807;"""";""None"";""328.41"";""0"";""1.51"";""BDBM585026"";""O=C1CC(c2ccccc2)CC(=O)C1=CNCCN1CCOCC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230262"";""UO_0000065"";""15.36"";""0.29"";""3.54"";""8.60"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL3212229;"""";""None"";""431.60"";""0"";""2.96"";""BDBM585029"";""CCCCCC(=O)N1CCN(CCNC=C2C(=O)CC(c3cccs3)CC2=O)CC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230265"";""UO_0000065"";""11.69"";""0.23"";""2.09"";""7.24"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL5959505;"""";""None"";""471.47"";""0"";""2.10"";""BDBM499993"";""O=C1CCC(N2C(=O)c3cccc(NC=C4C(=O)CC(c5ccccc5)CC4=O)c3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041896"";""UO_0000065"";""12.99"";""0.24"";""4.02"";""4.72"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5965953;"""";""None"";""496.52"";""0"";""2.94"";""BDBM499994"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5cccc6[nH]ccc56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041897"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5812235;"""";""None"";""497.51"";""0"";""2.34"";""BDBM500035"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5cccc6[nH]ncc56)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041933"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5822287;"""";""None"";""517.54"";""1"";""2.48"";""BDBM500036"";""COc1ccc(C2CC(=O)C(=CNc3cccc4c3CN(C3CCC(=O)NC3=O)C4=O)C(=O)C2)c(OC)c1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041934"";""UO_0000065"";""11.83"";""0.22"";""3.64"";""4.67"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5881734;"""";""None"";""769.86"";""1"";""3.91"";""BDBM500039"";""O=C1CCC(N2Cc3c(NC(=O)[C@H](CCCNC=C4C(=O)CC(c5ccccc5)CC4=O)NC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1041937"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL6061485;"""";""None"";""726.79"";""2"";""1.16"";""BDBM500053"";""O=C1CCC(N2C(=O)c3cccc(NC(=O)CCC(=O)OCCN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)c3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041951"";""UO_0000065"";""8.43"";""0.16"";""4.96"";""3.20"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5969859;"""";""None"";""702.81"";""1"";""3.01"";""BDBM500085"";""O=C1CCC(N2Cc3c(NC(=O)c4ccc(CN5CCN(CCNC=C6C(=O)CC(c7ccccc7)CC6=O)CC5)cc4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041983"";""UO_0000065"";""9.33"";""0.17"";""3.55"";""4.43"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5800552;"""";""None"";""259.31"";""0"";""1.17"";""BDBM584981"";""O=C1CC(c2ccccc2)CC(=O)C1=CNCCO"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230217"";""UO_0000065"";""19.46"";""0.36"";""3.88"";""7.60"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL5923581;"""";""None"";""195.26"";""0"";""1.58"";""BDBM584996"";""CCCCNC=C1C(=O)CCCC1=O"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230232"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL4288264;"""";""None"";""288.30"";""0"";""2.85"";""BDBM584999"";""CC1(C)CC(=O)C(=CNc2ccc([N+](=O)[O-])cc2)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230235"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL4287717;"""";""None"";""277.75"";""0"";""3.59"";""BDBM585000"";""CC1(C)CC(=O)C(=CNc2ccc(Cl)cc2)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230236"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5803936;"""";""None"";""322.20"";""0"";""2.91"";""BDBM584979"";""CN(C)C=C1C(=O)CC(c2ccccc2Br)CC1=O"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230215"";""UO_0000065"";""15.66"";""0.36"";""2.14"";""13.50"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL1535164;"""";""None"";""291.35"";""0"";""3.70"";""BDBM584983"";""O=C1CC(c2ccccc2)CC(=O)C1=CNc1ccccc1"";""IC50"";""'='"";""57500.0"";""nM"";""4.24"";"""";""1230219"";""UO_0000065"";""14.55"";""0.26"";""0.54"";""9.18"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""57500.0"""
"CHEMBL5803558;"""";""None"";""209.29"";""0"";""1.78"";""BDBM584991"";""CCCC1CC(=O)C(=CN(C)C)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230227"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5755568;"""";""None"";""409.49"";""0"";""3.59"";""BDBM50085"";""CC1(C)CC(=O)C(=CNc2cccc(NC=C3C(=O)CC(C)(C)CC3=O)n2)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230242"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL3190151;"""";""None"";""484.60"";""0"";""1.85"";""BDBM585002"";""CCOC(=O)c1ccc(NC(=O)CN2CCN(CCNC=C3C(=O)CC(C)(C)CC3=O)CC2)cc1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230238"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL1582103;"""";""None"";""497.06"";""0"";""3.84"";""BDBM56364"";""O=C1CC(c2ccccc2)CC(=O)C1=CNCCN1CCN(C(=S)Nc2cccc(Cl)c2)CC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230239"";""UO_0000065"";""10.15"";""0.20"";""1.21"";""7.80"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL1483454;"""";""None"";""416.55"";""0"";""1.45"";""BDBM55432"";""C=CCNC(=S)N1CCN(CCNC=C2C(=O)CC(c3ccco3)CC2=O)CC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230247"";""UO_0000065"";""12.11"";""0.24"";""3.60"";""6.48"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL1430514;"""";""None"";""361.87"";""0"";""1.73"";""BDBM585023"";""O=C1CC(c2ccc(Cl)cc2)CC(=O)C1=CNCCN1CCNCC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230259"";""UO_0000065"";""13.94"";""0.28"";""3.32"";""8.21"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL3213875;"""";""None"";""273.33"";""0"";""1.56"";""BDBM584982"";""O=C1CC(c2ccccc2)CC(=O)C1=CNCCCO"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230218"";""UO_0000065"";""18.46"";""0.34"";""3.49"";""7.60"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL5746000;"""";""None"";""306.37"";""0"";""2.77"";""BDBM584985"";""O=C1CC(c2ccccc2)CC(=O)C1=CNCc1ccccn1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230221"";""UO_0000065"";""16.47"";""0.30"";""2.28"";""8.54"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL6064084;"""";""None"";""196.21"";""0"";""0.12"";""BDBM584997"";""CNC(=O)NC=C1C(=O)CCCC1=O"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230233"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5942062;"""";""None"";""541.48"";""1"";""3.36"";""BDBM500018"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5ccc(OC(F)(F)F)cc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041916"";""UO_0000065"";""11.31"";""0.21"";""2.76"";""5.03"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5853765;"""";""None"";""588.82"";""1"";""4.01"";""BDBM500002"";""O=C1CCC(N2Cc3c(NC=C4C(=O)CC(c5c(Br)ccc(F)c5Cl)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041905"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL6051157;"""";""None"";""279.34"";""0"";""0.44"";""BDBM585027"";""CC1(C)CC(=O)C(=CNCCN2CCNC2=O)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230263"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5896143;"""";""None"";""243.31"";""0"";""2.15"";""BDBM584973"";""CN(C)C=C1C(=O)CC(c2ccccc2)CC1=O"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230209"";""UO_0000065"";""20.74"";""0.38"";""2.90"";""13.50"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL6029496;"""";""None"";""261.30"";""0"";""2.29"";""BDBM584976"";""CN(C)C=C1C(=O)CC(c2ccc(F)cc2)CC1=O"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230212"";""UO_0000065"";""19.31"";""0.36"";""2.76"";""13.50"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL5827431;"""";""None"";""510.51"";""1"";""2.58"";""BDBM499996"";""O=C1CCC(N2C(=O)c3cccc(NC=C4C(=O)CC(c5cccc6[nH]ccc56)CC4=O)c3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041899"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5786429;"""";""None"";""231.25"";""0"";""1.56"";""BDBM584974"";""O=C1CC(c2ccccc2)CC(=O)C1=CNO"";""IC50"";""'='"";""57500.0"";""nM"";""4.24"";"""";""1230210"";""UO_0000065"";""18.34"";""0.34"";""2.68"";""6.39"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""57500.0"""
"CHEMBL5929673;"""";""None"";""257.33"";""0"";""2.46"";""BDBM584975"";""Cc1ccc(C2CC(=O)C(=CN(C)C)C(=O)C2)cc1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230211"";""UO_0000065"";""19.61"";""0.36"";""2.59"";""13.50"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL3194411;"""";""None"";""335.45"";""0"";""0.97"";""BDBM56282"";""CCC(=O)N1CCN(CCNC=C2C(=O)CC(C)(C)CC2=O)CC1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230216"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5880470;"""";""None"";""495.02"";""0"";""3.09"";""BDBM585005"";""O=C(CN1CCN(CCNC=C2C(=O)CC(c3ccccc3)CC2=O)CC1)Nc1ccc(Cl)cc1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230241"";""UO_0000065"";""10.19"";""0.20"";""1.96"";""6.17"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL5887369;"""";""None"";""470.66"";""0"";""2.12"";""BDBM585008"";""CC1(C)CC(=O)C(=CNCCN2CCN(CC(=O)NC34CC5CC(CC(C5)C3)C4)CC2)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230244"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5818668;"""";""None"";""366.49"";""0"";""3.12"";""BDBM584986"";""O=C1CC(c2cccs2)CC(=O)C1=CNCC1NCCc2ccccc21"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230222"";""UO_0000065"";""13.77"";""0.27"";""1.93"";""8.67"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL5954868;"""";""None"";""281.31"";""0"";""3.29"";""BDBM584987"";""O=C1CC(c2ccco2)CC(=O)C1=CNc1ccccc1"";""IC50"";""'='"";""57500.0"";""nM"";""4.24"";"""";""1230223"";""UO_0000065"";""15.07"";""0.28"";""0.95"";""7.15"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""57500.0"""
"CHEMBL3196625;"""";""None"";""323.40"";""0"";""3.64"";""BDBM40959"";""Cc1n[nH]c(NC=C2C(=O)CC(C)(C)CC2=O)c1-c1ccccc1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230225"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL3209713;"""";""None"";""375.49"";""0"";""1.40"";""BDBM585012"";""CC(=O)N1CCN(CCNC=C2C(=O)CC(c3cccs3)CC2=O)CC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230248"";""UO_0000065"";""13.44"";""0.27"";""3.65"";""7.24"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL1401560;"""";""None"";""302.37"";""0"";""1.77"";""BDBM585019"";""O=C1CC(c2ccco2)CC(=O)C1=CNCC1CCNCC1"";""IC50"";""'='"";""9000.0"";""nM"";""5.05"";"""";""1230255"";""UO_0000065"";""16.69"";""0.31"";""3.28"";""7.07"";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""9000.0"""
"CHEMBL5743143;"""";""None"";""211.26"";""0"";""0.63"";""BDBM584992"";""COCC1CC(=O)C(=CN(C)C)C(=O)C1"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230228"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5897877;"""";""None"";""181.24"";""0"";""1.00"";""BDBM584995"";""CC1CCC(=O)/C(=C\N(C)C)C1=O"";""IC50"";""'='"";""550000.0"";""nM"";"""";""Outside typical range"";""1230231"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5738767"";""Molecular Level Experiments of Targeting LC3B : By constructing a prokaryotic expression system", the LC3B protein was expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of synthesized small compound libraries.The recombinant protein GST-LC3B (final concentration 180 nM, SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/mL BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the resulting mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5729475"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2022"";""None"";"""";"""";"""";""550000.0"""
"CHEMBL5940111;"""";""None"";""457.49"";""0"";""2.46"";""BDBM499999"";""O=C1CCC(N2Cc3cc(NC=C4C(=O)CC(c5ccccc5)CC4=O)ccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041902"";""UO_0000065"";""13.39"";""0.25"";""3.66"";""5.44"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL6037457;"""";""None"";""623.85"";""1"";""4.00"";""BDBM500004"";""O=C1CCC(N2C(=O)c3cccc(NC=C4C(=O)CC(c5c(Br)ccc6[nH]cc(Cl)c56)CC4=O)c3C2=O)C(=O)N1"";""IC50"";""'<'"";""3.0"";""nM"";"""";"""";""1041907"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""3.0""",
"CHEMBL5995596;"""";""None"";""542.59"";""1"";""2.36"";""BDBM500043"";""O=C1CCC(N2Cc3c(NC(=O)CCCNC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1041941"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL5761708;"""";""None"";""576.61"";""1"";""3.71"";""BDBM500048"";""O=C1CCC(N2Cc3c(NC(=O)c4ccccc4NC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041946"";""UO_0000065"";""11.38"";""0.21"";""2.85"";""4.63"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5949220;"""";""None"";""640.70"";""1"";""0.83"";""BDBM500051"";""O=C1CCC(N2C(=O)c3cccc(NC(=O)CN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)c3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041949"";""UO_0000065"";""9.56"";""0.18"";""5.29"";""3.71"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5989894;"""";""None"";""740.77"";""2"";""1.39"";""BDBM500078"";""O=C1CCC(N2Cc3c(NC(=O)OCOC(=O)/C=C/C(=O)N4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041976"";""UO_0000065"";""8.86"";""0.17"";""5.17"";""3.27"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5970022;"""";""None"";""627.70"";""1"";""1.27"";""BDBM500094"";""O=C1CCC(N2C(=O)c3cccc(OCCN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)c3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1041992"";""UO_0000065"";""10.45"";""0.19"";""5.29"";""4.51"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5839630;"""";""None"";""500.56"";""1"";""2.05"";""BDBM500096"";""O=C1CCC(N2Cc3c(NCCNC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""750.0"";""nM"";""6.12"";"""";""1041994"";""UO_0000065"";""12.24"";""0.23"";""4.07"";""4.91"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""750.0""",
"CHEMBL5829539;"""";""None"";""459.46"";""0"";""0.69"";""BDBM500103"";""O=C1CCC(N2Cc3c(NC=C4C(=O)NC(c5ccccc5)NC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042001"";""UO_0000065"";""14.28"";""0.26"";""5.87"";""4.80"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
"CHEMBL5864333;"""";""None"";""515.52"";""1"";""2.00"";""BDBM500110"";""O=C1CCC(N2Cc3c(NC(=O)COC=C4C(=O)CC(c5ccccc5)CC4=O)cccc3C2=O)C(=O)N1"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1042008"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL5778089;"""";""None"";""473.53"";""0"";""2.92"";""BDBM500116"";""CCC(=O)/C(=C/Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCc1ccccc1"";""IC50"";""'<'"";""50.0"";""nM"";"""";"""";""1042014"";""UO_0000065"";"""";"""";"""";"""";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""50.0""",
"CHEMBL5929728;"""";""None"";""757.89"";""2"";""2.24"";""BDBM500117"";""O=C1CCC(N2C(=O)c3cccc(NCCOCCOCCOCCN4CCN(CCNC=C5C(=O)CC(c6ccccc6)CC5=O)CC4)c3C2=O)C(=O)C1"";""IC50"";""'='"";""275.0"";""nM"";""6.56"";"""";""1042015"";""UO_0000065"";""8.66"";""0.16"";""4.32"";""4.00"";""0"";""CHEMBL5736871"";""Assay Targeting LC3B: By constructing a prokaryotic expression system", the LC3B protein was successfully expressed and purified, and a preliminary screening and verification platform was established using fluorescence polarization experiments to determine the activity of purchased and synthesized small compound libraries. The recombinant protein GST-LC3B (final concentration 180 nM) (SEQ ID NO: 1) and N-terminal FITC-labeled peptide (SEQ ID NO: 2, final concentration 18 nM) were placed in the FP buffer (50 mM HEPES pH 7.5, 0.1 mg/ml BSA and 1 mM DTT), to which a compound serially diluted with the FP buffer was added. Then the mixture was incubated at 25° C. in the dark. The fluorescence polarization value (PerkinElmer Envision, emission wavelength 480 nm; absorption wavelength 535 nm) was monitored," and the IC50 value was calculated using the GraphPad Prism 6.0 program."";""B"";""BAO_0000019"";""assay format"";""None"";""None"";""None"";""None"";""None"";"""";"""";"""";""CHEMBL4879514"";""Microtubule-associated proteins 1A/1B light chain 3B"";""Homo sapiens"";""SINGLE PROTEIN"";""CHEMBL5728490"";""37"";""BindingDB Patent Bioactivity Data"";"""";""2021"";""None"";"""";"""";"""";""275.0""",
